BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang R, Xu B, Yang B, Fu J, Chen H, Wang X. Non-coding RNAs: the extensive and interactive regulators of the blood-brain barrier permeability. RNA Biol 2021;:1-9. [PMID: 34241576 DOI: 10.1080/15476286.2021.1950465] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 D'Anca M, Buccellato FR, Fenoglio C, Galimberti D. Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration. Int J Mol Sci 2022;23:4134. [PMID: 35456950 DOI: 10.3390/ijms23084134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Sun P, Hamblin MH, Yin K. Non-coding RNAs in the regulation of blood–brain barrier functions in central nervous system disorders. Fluids Barriers CNS 2022;19. [DOI: 10.1186/s12987-022-00317-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Z, Zhu J, Wang Y. ADAR3 alleviated inflammation and pyroptosis of neuropathic pain by targeting NLRP3 in chronic constriction injury mice. Gene 2021;805:145909. [PMID: 34419568 DOI: 10.1016/j.gene.2021.145909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Das T, Das TK, Khodarkovskaya A, Dash S. Non-coding RNAs and their bioengineering applications for neurological diseases. Bioengineered 2021. [PMID: 34756133 DOI: 10.1080/21655979.2021.2003667] [Reference Citation Analysis]
5 Riscado M, Baptista B, Sousa F. New RNA-Based Breakthroughs in Alzheimer's Disease Diagnosis and Therapeutics. Pharmaceutics 2021;13:1397. [PMID: 34575473 DOI: 10.3390/pharmaceutics13091397] [Cited by in F6Publishing: 2] [Reference Citation Analysis]